Cambrex

About

Company description

Cambrex is the leading small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world.

We put all of our energy and experience into being your partner of choice
We create value for customers through manufacturing excellence, reliable quality and innovative science
Our people are the experts that our customers enjoy working with We truly offer our customers an end-to-end partnership for the research, development and manufacture of small molecule therapeutics at every stage of the drug lifecycle.

Quick facts

Affiliated categories:	API Contract Manufacturing \|Bio Services \|Contract Manufacturing More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 2F30 Book a meeting See our Exhibitor Profile See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 41C10 See our Exhibitor Profile See full Exhibitor List

18 jun 2019

CPhI & PMEC China 2019

18 - 20 June 2019 SNIEC, Shanghai, China We were at stand E1A58 See our Exhibitor Profile See full Exhibitor List

30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 1006 See our Exhibitor Profile See full Exhibitor List

News about Cambrex

7 Apr 2020

CDMO Cambrex completes biopharmaceutical expansion at Durham, NC facility

Cambrex has completed an expansion of biopharmaceutical analysis capabilities at its Durham, North Carolina site, the contract development and manufacturing organisation said Tuesday.

9 Dec 2019

Permira Funds completes acquisition of Cambrex

The transaction will enhance Cambrex's ability to service its global customer base and broaden its capabilities to provide additional world-class services.

30 Jul 2019

Cambrex to double size of Edinburgh solid form screening facility

The expanded laboratory space will allow the installation of additional instruments and reactors for larger scale crystallization studies and solid form screening capabilities.

5 Jun 2019